News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Brensocatib has no impact on COVID-19 clinical outcomes
02 Oct 2022
byRoshini Claire Anthony
Results of the STOP-COVID trial, presented at ERS 2022, showed no clinical outcome benefit with the dipeptidyl peptidase-1 (DPP-1) inhibitor brensocatib compared with placebo in patients hospitalized with COVID-19 in the UK.
02 Oct 2022







